 Charles Robertson
Concepts (525)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 44 | 2024 | 761 | 3.560 |
Why?
| | Gastrointestinal Microbiome | 31 | 2025 | 701 | 2.620 |
Why?
| | RNA, Ribosomal, 16S | 45 | 2024 | 553 | 1.650 |
Why?
| | Bacteria | 31 | 2023 | 873 | 1.540 |
Why?
| | Intestinal Mucosa | 11 | 2025 | 621 | 0.940 |
Why?
| | Otitis Media | 6 | 2025 | 167 | 0.930 |
Why?
| | Cystic Fibrosis | 12 | 2023 | 1106 | 0.870 |
Why?
| | Feces | 17 | 2025 | 481 | 0.800 |
Why?
| | Intestines | 9 | 2017 | 354 | 0.750 |
Why?
| | Metagenome | 10 | 2019 | 151 | 0.720 |
Why?
| | Nasopharynx | 5 | 2024 | 73 | 0.670 |
Why?
| | Rhinitis | 6 | 2020 | 157 | 0.650 |
Why?
| | Biodiversity | 11 | 2020 | 419 | 0.640 |
Why?
| | Water Microbiology | 8 | 2018 | 85 | 0.630 |
Why?
| | Sinusitis | 6 | 2020 | 221 | 0.610 |
Why?
| | Paranasal Sinuses | 5 | 2016 | 76 | 0.560 |
Why?
| | Colon | 4 | 2025 | 286 | 0.520 |
Why?
| | Arthritis, Experimental | 3 | 2024 | 140 | 0.510 |
Why?
| | Phylogeny | 13 | 2020 | 1009 | 0.510 |
Why?
| | Air Microbiology | 2 | 2015 | 47 | 0.510 |
Why?
| | Archaea | 2 | 2008 | 85 | 0.510 |
Why?
| | Ileum | 4 | 2020 | 109 | 0.480 |
Why?
| | Sequence Analysis, DNA | 14 | 2020 | 828 | 0.480 |
Why?
| | Breast Feeding | 6 | 2025 | 434 | 0.460 |
Why?
| | RNA, Bacterial | 8 | 2018 | 188 | 0.440 |
Why?
| | Database Management Systems | 1 | 2013 | 51 | 0.410 |
Why?
| | Computer Graphics | 1 | 2013 | 41 | 0.410 |
Why?
| | Railroads | 1 | 2013 | 5 | 0.410 |
Why?
| | User-Computer Interface | 1 | 2013 | 162 | 0.380 |
Why?
| | Aerosols | 1 | 2013 | 178 | 0.370 |
Why?
| | Geologic Sediments | 2 | 2008 | 46 | 0.360 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 109 | 0.360 |
Why?
| | Trachea | 4 | 2023 | 249 | 0.360 |
Why?
| | Colitis | 3 | 2025 | 267 | 0.350 |
Why?
| | HIV Infections | 5 | 2025 | 2945 | 0.340 |
Why?
| | Infant Nutritional Physiological Phenomena | 3 | 2025 | 145 | 0.340 |
Why?
| | Inflammation | 11 | 2025 | 2847 | 0.330 |
Why?
| | Crohn Disease | 4 | 2020 | 244 | 0.330 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.330 |
Why?
| | Dysbiosis | 5 | 2023 | 182 | 0.310 |
Why?
| | Lung | 7 | 2021 | 4065 | 0.310 |
Why?
| | Humans | 80 | 2025 | 138102 | 0.310 |
Why?
| | DNA, Bacterial | 8 | 2021 | 337 | 0.310 |
Why?
| | Genes, rRNA | 5 | 2015 | 42 | 0.290 |
Why?
| | Software | 1 | 2013 | 665 | 0.280 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2022 | 279 | 0.280 |
Why?
| | Male | 53 | 2025 | 67984 | 0.280 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 178 | 0.270 |
Why?
| | Case-Control Studies | 15 | 2020 | 3569 | 0.270 |
Why?
| | Female | 54 | 2025 | 73648 | 0.270 |
Why?
| | Mice | 23 | 2025 | 17769 | 0.270 |
Why?
| | Sulfolobus solfataricus | 1 | 2007 | 9 | 0.260 |
Why?
| | Bronchoalveolar Lavage Fluid | 4 | 2021 | 643 | 0.260 |
Why?
| | Animals | 32 | 2025 | 37151 | 0.250 |
Why?
| | Legionella | 2 | 2017 | 7 | 0.250 |
Why?
| | Water Pollutants, Chemical | 2 | 2020 | 217 | 0.250 |
Why?
| | HIV-1 | 2 | 2024 | 887 | 0.240 |
Why?
| | Dietary Supplements | 3 | 2019 | 565 | 0.240 |
Why?
| | Drinking Water | 3 | 2017 | 84 | 0.240 |
Why?
| | Cryoelectron Microscopy | 1 | 2007 | 190 | 0.240 |
Why?
| | Fatty Liver | 2 | 2021 | 242 | 0.240 |
Why?
| | Blueberry Plants | 1 | 2025 | 7 | 0.240 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2925 | 0.240 |
Why?
| | Pseudomonas Infections | 3 | 2023 | 219 | 0.240 |
Why?
| | Fatty Acids, Volatile | 4 | 2019 | 58 | 0.240 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 34 | 0.240 |
Why?
| | Environmental Microbiology | 1 | 2005 | 53 | 0.230 |
Why?
| | Eosinophilic Esophagitis | 2 | 2022 | 325 | 0.230 |
Why?
| | Drug Resistance | 2 | 2017 | 145 | 0.230 |
Why?
| | Ear, Middle | 5 | 2025 | 84 | 0.230 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.220 |
Why?
| | Construction Materials | 2 | 2015 | 16 | 0.220 |
Why?
| | Pentanols | 1 | 2024 | 5 | 0.220 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 168 | 0.220 |
Why?
| | Colitis, Ulcerative | 2 | 2020 | 136 | 0.220 |
Why?
| | Lyases | 1 | 2024 | 14 | 0.220 |
Why?
| | Metagenomics | 3 | 2019 | 179 | 0.220 |
Why?
| | Bacteremia | 2 | 2018 | 214 | 0.220 |
Why?
| | Staphylococcus aureus | 4 | 2021 | 432 | 0.220 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2017 | 541 | 0.220 |
Why?
| | Th17 Cells | 1 | 2025 | 108 | 0.210 |
Why?
| | Liver | 3 | 2020 | 1874 | 0.210 |
Why?
| | Adult | 30 | 2025 | 38063 | 0.210 |
Why?
| | Mice, Inbred C57BL | 13 | 2025 | 5769 | 0.210 |
Why?
| | Ecosystem | 2 | 2007 | 607 | 0.210 |
Why?
| | Infant Formula | 2 | 2023 | 73 | 0.210 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2017 | 3664 | 0.210 |
Why?
| | Butyrates | 1 | 2024 | 60 | 0.210 |
Why?
| | Sputum | 5 | 2020 | 304 | 0.210 |
Why?
| | Adrenal Cortex Hormones | 3 | 2017 | 491 | 0.210 |
Why?
| | Respiratory Tract Infections | 3 | 2024 | 384 | 0.210 |
Why?
| | Child | 22 | 2025 | 21990 | 0.210 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 109 | 0.210 |
Why?
| | Respiratory System | 2 | 2016 | 155 | 0.200 |
Why?
| | Diet, Western | 2 | 2022 | 81 | 0.200 |
Why?
| | Premature Birth | 3 | 2017 | 340 | 0.200 |
Why?
| | Imaging, Three-Dimensional | 1 | 2007 | 564 | 0.200 |
Why?
| | Milk, Human | 3 | 2023 | 156 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2025 | 226 | 0.200 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 266 | 0.190 |
Why?
| | Staphylococcus | 4 | 2017 | 75 | 0.190 |
Why?
| | Bile Acids and Salts | 2 | 2022 | 154 | 0.190 |
Why?
| | Iron | 2 | 2016 | 324 | 0.190 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.190 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2018 | 350 | 0.190 |
Why?
| | Hypersensitivity | 1 | 2025 | 252 | 0.190 |
Why?
| | Arthritis, Rheumatoid | 2 | 2023 | 1157 | 0.190 |
Why?
| | Cholesteatoma | 1 | 2022 | 10 | 0.190 |
Why?
| | Anti-Bacterial Agents | 8 | 2023 | 1804 | 0.190 |
Why?
| | Gastrointestinal Tract | 3 | 2015 | 202 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 388 | 0.190 |
Why?
| | Infant | 12 | 2025 | 9566 | 0.180 |
Why?
| | Haemophilus Infections | 1 | 2022 | 41 | 0.180 |
Why?
| | Transcriptome | 3 | 2021 | 969 | 0.180 |
Why?
| | Diet | 3 | 2025 | 1290 | 0.170 |
Why?
| | Staphylococcal Infections | 3 | 2015 | 386 | 0.170 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 196 | 0.170 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.170 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.170 |
Why?
| | Oropharynx | 2 | 2024 | 45 | 0.170 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.170 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2021 | 53 | 0.170 |
Why?
| | Cross-Sectional Studies | 11 | 2021 | 5556 | 0.170 |
Why?
| | Perilipin-2 | 2 | 2017 | 41 | 0.170 |
Why?
| | Groundwater | 1 | 2020 | 40 | 0.170 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.160 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 258 | 0.160 |
Why?
| | Nasal Polyps | 1 | 2020 | 60 | 0.160 |
Why?
| | Mucin 5AC | 1 | 2020 | 70 | 0.160 |
Why?
| | Hot Springs | 2 | 2012 | 9 | 0.160 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 16 | 0.160 |
Why?
| | Birth Weight | 2 | 2020 | 511 | 0.160 |
Why?
| | Respiratory System Agents | 1 | 2020 | 22 | 0.160 |
Why?
| | RNA, Ribosomal | 4 | 2013 | 168 | 0.160 |
Why?
| | Biofilms | 3 | 2017 | 264 | 0.160 |
Why?
| | Inflammation Mediators | 2 | 2020 | 511 | 0.160 |
Why?
| | Bacteroides | 1 | 2019 | 21 | 0.150 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2017 | 387 | 0.150 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.150 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 141 | 0.150 |
Why?
| | Adolescent | 18 | 2021 | 21637 | 0.150 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4309 | 0.150 |
Why?
| | Middle Aged | 21 | 2024 | 33509 | 0.150 |
Why?
| | Polymerase Chain Reaction | 7 | 2017 | 1049 | 0.150 |
Why?
| | Esomeprazole | 1 | 2018 | 7 | 0.150 |
Why?
| | Vitamin B Complex | 1 | 2019 | 43 | 0.150 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 177 | 0.150 |
Why?
| | Diet, High-Fat | 2 | 2017 | 249 | 0.150 |
Why?
| | Burns | 1 | 2023 | 335 | 0.150 |
Why?
| | Chronic Disease | 7 | 2022 | 1791 | 0.150 |
Why?
| | Oxonic Acid | 1 | 2018 | 8 | 0.150 |
Why?
| | Asthma | 3 | 2017 | 1890 | 0.150 |
Why?
| | Biomarkers | 6 | 2025 | 4111 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 2 | 2025 | 2374 | 0.150 |
Why?
| | Alphaproteobacteria | 2 | 2016 | 9 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 44 | 0.140 |
Why?
| | Body Mass Index | 4 | 2020 | 2422 | 0.140 |
Why?
| | Vitamin B 12 | 1 | 2019 | 126 | 0.140 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 15 | 0.140 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 259 | 0.140 |
Why?
| | Corrosion | 2 | 2015 | 14 | 0.140 |
Why?
| | Chloramines | 2 | 2015 | 11 | 0.140 |
Why?
| | Hydraulic Fracking | 1 | 2018 | 16 | 0.140 |
Why?
| | Quinolones | 1 | 2020 | 134 | 0.140 |
Why?
| | Probiotics | 1 | 2018 | 56 | 0.140 |
Why?
| | Aminophenols | 1 | 2020 | 156 | 0.140 |
Why?
| | Immunity, Innate | 3 | 2019 | 826 | 0.140 |
Why?
| | Spondylarthritis | 1 | 2018 | 50 | 0.140 |
Why?
| | Dacryocystorhinostomy | 1 | 2017 | 12 | 0.140 |
Why?
| | Infant, Newborn | 8 | 2025 | 6140 | 0.130 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.130 |
Why?
| | Sequence Analysis, RNA | 3 | 2020 | 452 | 0.130 |
Why?
| | Clostridium Infections | 1 | 2018 | 72 | 0.130 |
Why?
| | Sepsis | 1 | 2023 | 602 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 486 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 554 | 0.130 |
Why?
| | Child, Preschool | 9 | 2025 | 11142 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 354 | 0.130 |
Why?
| | Respiration, Artificial | 3 | 2023 | 639 | 0.130 |
Why?
| | Pharynx | 1 | 2016 | 61 | 0.120 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 322 | 0.120 |
Why?
| | Pedigree | 3 | 2025 | 511 | 0.120 |
Why?
| | Vitamin E | 1 | 2016 | 123 | 0.120 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 17 | 0.120 |
Why?
| | Rivers | 1 | 2016 | 65 | 0.120 |
Why?
| | Lipid Metabolism | 2 | 2020 | 523 | 0.120 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 9 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 78 | 0.120 |
Why?
| | Young Adult | 11 | 2021 | 13329 | 0.120 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2016 | 58 | 0.120 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.120 |
Why?
| | Mice, Knockout | 5 | 2025 | 3014 | 0.120 |
Why?
| | Dietary Fats | 1 | 2017 | 305 | 0.120 |
Why?
| | Cytokines | 3 | 2025 | 2079 | 0.120 |
Why?
| | Lactobacillus | 3 | 2022 | 29 | 0.120 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 21 | 0.120 |
Why?
| | Base Sequence | 3 | 2015 | 2180 | 0.120 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 145 | 0.120 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.120 |
Why?
| | Nose | 1 | 2015 | 65 | 0.120 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 64 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 85 | 0.120 |
Why?
| | Bronchi | 1 | 2016 | 267 | 0.110 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.110 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 40 | 0.110 |
Why?
| | Biota | 1 | 2015 | 35 | 0.110 |
Why?
| | Prospective Studies | 7 | 2022 | 7603 | 0.110 |
Why?
| | Household Articles | 1 | 2014 | 27 | 0.110 |
Why?
| | Humidity | 1 | 2014 | 50 | 0.110 |
Why?
| | Siblings | 1 | 2015 | 216 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 242 | 0.110 |
Why?
| | Rats | 6 | 2023 | 5564 | 0.110 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 119 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 618 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 611 | 0.110 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 134 | 0.110 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2014 | 62 | 0.110 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 28 | 0.110 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 44 | 0.110 |
Why?
| | Cecum | 3 | 2020 | 32 | 0.100 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 48 | 0.100 |
Why?
| | Parenteral Nutrition | 1 | 2014 | 104 | 0.100 |
Why?
| | Nasal Cavity | 1 | 2013 | 54 | 0.100 |
Why?
| | Age Factors | 2 | 2019 | 3285 | 0.100 |
Why?
| | DNA, Ribosomal | 2 | 2015 | 90 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 1002 | 0.100 |
Why?
| | Hippocampus | 1 | 2018 | 903 | 0.100 |
Why?
| | Cities | 1 | 2013 | 133 | 0.100 |
Why?
| | Bacteroidetes | 3 | 2021 | 24 | 0.100 |
Why?
| | Autoantibodies | 2 | 2018 | 1454 | 0.100 |
Why?
| | Saliva | 1 | 2015 | 239 | 0.100 |
Why?
| | Computational Biology | 2 | 2019 | 649 | 0.100 |
Why?
| | Aged | 11 | 2023 | 23995 | 0.100 |
Why?
| | Soil Microbiology | 1 | 2015 | 222 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 817 | 0.100 |
Why?
| | New York City | 1 | 2013 | 86 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 63 | 0.100 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 102 | 0.100 |
Why?
| | Iron, Dietary | 1 | 2013 | 22 | 0.100 |
Why?
| | Pediatric Obesity | 1 | 2020 | 612 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2019 | 1154 | 0.100 |
Why?
| | Gastric Bypass | 1 | 2014 | 118 | 0.100 |
Why?
| | Prednisone | 1 | 2013 | 216 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2021 | 348 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 588 | 0.100 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 240 | 0.100 |
Why?
| | Infant Food | 1 | 2013 | 64 | 0.100 |
Why?
| | Seawater | 1 | 2012 | 31 | 0.100 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 232 | 0.100 |
Why?
| | Paneth Cells | 1 | 2012 | 16 | 0.100 |
Why?
| | Bacterial Infections | 1 | 2014 | 244 | 0.090 |
Why?
| | Pregnancy | 6 | 2025 | 6789 | 0.090 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 236 | 0.090 |
Why?
| | Xenobiotics | 1 | 2012 | 31 | 0.090 |
Why?
| | Mexico | 2 | 2012 | 232 | 0.090 |
Why?
| | Carbon Dioxide | 1 | 2014 | 269 | 0.090 |
Why?
| | Bacterial Translocation | 1 | 2012 | 44 | 0.090 |
Why?
| | Body Fluids | 1 | 2012 | 71 | 0.090 |
Why?
| | Islets of Langerhans | 2 | 2015 | 793 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 139 | 0.090 |
Why?
| | Sequence Analysis | 1 | 2011 | 36 | 0.090 |
Why?
| | Autoimmunity | 2 | 2015 | 899 | 0.080 |
Why?
| | Kidney | 1 | 2018 | 1475 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2014 | 269 | 0.080 |
Why?
| | Esophagus | 1 | 2012 | 255 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2018 | 1122 | 0.080 |
Why?
| | Autism Spectrum Disorder | 1 | 2015 | 401 | 0.080 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 418 | 0.080 |
Why?
| | Genes, Bacterial | 3 | 2018 | 166 | 0.080 |
Why?
| | Phenotype | 5 | 2020 | 3158 | 0.080 |
Why?
| | Indoles | 1 | 2013 | 408 | 0.080 |
Why?
| | Obesity | 2 | 2021 | 3037 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 84 | 0.080 |
Why?
| | Genotype | 4 | 2019 | 1876 | 0.080 |
Why?
| | Cholesterol | 2 | 2022 | 411 | 0.080 |
Why?
| | Pseudomonas aeruginosa | 2 | 2023 | 347 | 0.080 |
Why?
| | Cohort Studies | 5 | 2019 | 5731 | 0.080 |
Why?
| | Pacific Ocean | 1 | 2008 | 8 | 0.080 |
Why?
| | RNA, Archaeal | 1 | 2008 | 11 | 0.080 |
Why?
| | DNA, Archaeal | 1 | 2008 | 17 | 0.080 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 158 | 0.070 |
Why?
| | Weight Loss | 1 | 2014 | 791 | 0.070 |
Why?
| | Firmicutes | 2 | 2021 | 19 | 0.070 |
Why?
| | Exome | 2 | 2020 | 234 | 0.070 |
Why?
| | Smoke | 2 | 2023 | 145 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2562 | 0.070 |
Why?
| | Methane | 2 | 2020 | 51 | 0.070 |
Why?
| | Sex Characteristics | 1 | 2013 | 770 | 0.070 |
Why?
| | Bacterial Load | 2 | 2021 | 68 | 0.070 |
Why?
| | Cryoprotective Agents | 1 | 2007 | 10 | 0.070 |
Why?
| | Fatty Acids | 2 | 2022 | 446 | 0.070 |
Why?
| | Models, Statistical | 1 | 2011 | 665 | 0.070 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2007 | 61 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2025 | 1922 | 0.060 |
Why?
| | Freezing | 1 | 2007 | 88 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 1029 | 0.060 |
Why?
| | Gammaproteobacteria | 2 | 2016 | 13 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 979 | 0.060 |
Why?
| | Equipment Contamination | 2 | 2017 | 68 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2010 | 738 | 0.060 |
Why?
| | Genes, Archaeal | 1 | 2005 | 6 | 0.060 |
Why?
| | Disease Susceptibility | 2 | 2020 | 348 | 0.060 |
Why?
| | Cryopreservation | 1 | 2007 | 103 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 193 | 0.060 |
Why?
| | Insulin | 1 | 2016 | 2405 | 0.060 |
Why?
| | Rats, Inbred Lew | 2 | 2017 | 113 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2013 | 1059 | 0.060 |
Why?
| | Hexanols | 1 | 2024 | 4 | 0.060 |
Why?
| | Body Composition | 2 | 2021 | 695 | 0.060 |
Why?
| | Fruit | 1 | 2025 | 144 | 0.060 |
Why?
| | Water Purification | 2 | 2017 | 151 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2586 | 0.050 |
Why?
| | Methylamines | 1 | 2024 | 34 | 0.050 |
Why?
| | Mice, Inbred DBA | 1 | 2024 | 199 | 0.050 |
Why?
| | Treatment Outcome | 5 | 2020 | 10832 | 0.050 |
Why?
| | Disinfection | 2 | 2017 | 126 | 0.050 |
Why?
| | Gestational Age | 2 | 2017 | 915 | 0.050 |
Why?
| | Tobramycin | 1 | 2023 | 51 | 0.050 |
Why?
| | Administration, Oral | 2 | 2019 | 786 | 0.050 |
Why?
| | RNA, Messenger | 3 | 2018 | 2799 | 0.050 |
Why?
| | Geography | 2 | 2014 | 204 | 0.050 |
Why?
| | Choline | 1 | 2024 | 131 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 7638 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 557 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1495 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 120 | 0.050 |
Why?
| | Colorado | 3 | 2020 | 4553 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 37 | 0.050 |
Why?
| | Azithromycin | 1 | 2023 | 98 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 63 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 55 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 861 | 0.050 |
Why?
| | Cotinine | 1 | 2023 | 77 | 0.050 |
Why?
| | Neutrophils | 2 | 2021 | 1270 | 0.050 |
Why?
| | Neoplasms | 1 | 2018 | 2712 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 227 | 0.050 |
Why?
| | Brain | 1 | 2014 | 2725 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 183 | 0.050 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 10 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 267 | 0.050 |
Why?
| | Water | 2 | 2018 | 468 | 0.050 |
Why?
| | Administration, Inhalation | 1 | 2023 | 588 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2017 | 1194 | 0.050 |
Why?
| | Gastritis | 1 | 2022 | 109 | 0.050 |
Why?
| | Multigene Family | 2 | 2012 | 200 | 0.040 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 55 | 0.040 |
Why?
| | Enteritis | 1 | 2022 | 102 | 0.040 |
Why?
| | Endoscopy | 2 | 2015 | 313 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2861 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 666 | 0.040 |
Why?
| | Collagen | 1 | 2023 | 454 | 0.040 |
Why?
| | Aerobiosis | 1 | 2020 | 22 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2029 | 0.040 |
Why?
| | Mice, Inbred NOD | 2 | 2013 | 597 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2013 | 753 | 0.040 |
Why?
| | Ear, External | 1 | 2020 | 21 | 0.040 |
Why?
| | Oil and Gas Fields | 1 | 2020 | 32 | 0.040 |
Why?
| | Bacterial Proteins | 2 | 2018 | 897 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 222 | 0.040 |
Why?
| | Eosinophilia | 1 | 2022 | 217 | 0.040 |
Why?
| | Hospitals | 2 | 2015 | 694 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 95 | 0.040 |
Why?
| | Smoking | 2 | 2020 | 1616 | 0.040 |
Why?
| | Carcinogenesis | 1 | 2022 | 216 | 0.040 |
Why?
| | Mouth | 1 | 2020 | 87 | 0.040 |
Why?
| | Cell Line | 2 | 2018 | 2865 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 544 | 0.040 |
Why?
| | Sweat | 1 | 2020 | 47 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 116 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 367 | 0.040 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 10 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 138 | 0.040 |
Why?
| | Restraint, Physical | 1 | 2018 | 71 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 56 | 0.040 |
Why?
| | Forced Expiratory Volume | 1 | 2020 | 481 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 183 | 0.040 |
Why?
| | Collagen Type II | 1 | 2018 | 54 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 127 | 0.040 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 103 | 0.040 |
Why?
| | Environmental Monitoring | 1 | 2020 | 371 | 0.040 |
Why?
| | Risk Factors | 3 | 2017 | 10433 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 362 | 0.030 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2017 | 37 | 0.030 |
Why?
| | Prognosis | 2 | 2020 | 3982 | 0.030 |
Why?
| | New Orleans | 1 | 2017 | 14 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 2018 | 96 | 0.030 |
Why?
| | Bacterial Toxins | 1 | 2018 | 104 | 0.030 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Chorioamnionitis | 1 | 2017 | 42 | 0.030 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 70 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 165 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 448 | 0.030 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 66 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 487 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2017 | 198 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1260 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 89 | 0.030 |
Why?
| | Critical Illness | 1 | 2023 | 806 | 0.030 |
Why?
| | Betaproteobacteria | 1 | 2016 | 6 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Water Supply | 1 | 2017 | 78 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 618 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 67 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 184 | 0.030 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 328 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 29 | 0.030 |
Why?
| | Ohio | 1 | 2016 | 146 | 0.030 |
Why?
| | Bacillus | 1 | 2015 | 16 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 108 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 635 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 730 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 255 | 0.030 |
Why?
| | Antibiosis | 1 | 2015 | 10 | 0.030 |
Why?
| | Streptococcus mitis | 1 | 2015 | 10 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3608 | 0.030 |
Why?
| | Catalase | 1 | 2015 | 133 | 0.030 |
Why?
| | Pre-Eclampsia | 1 | 2017 | 189 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 79 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 1012 | 0.030 |
Why?
| | Pseudomonas | 1 | 2015 | 30 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 32 | 0.030 |
Why?
| | Rectum | 1 | 2016 | 188 | 0.030 |
Why?
| | Carrier State | 1 | 2015 | 69 | 0.030 |
Why?
| | Kenya | 1 | 2015 | 123 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 848 | 0.030 |
Why?
| | Pennsylvania | 1 | 2015 | 132 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 521 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 22 | 0.030 |
Why?
| | Enterobacteriaceae | 1 | 2015 | 42 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Proteobacteria | 1 | 2014 | 16 | 0.030 |
Why?
| | Plant Oils | 1 | 2014 | 32 | 0.030 |
Why?
| | DNA | 2 | 2014 | 1448 | 0.030 |
Why?
| | Corynebacterium | 1 | 2015 | 49 | 0.030 |
Why?
| | Physical Exertion | 1 | 2015 | 209 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 161 | 0.030 |
Why?
| | Kupffer Cells | 1 | 2014 | 49 | 0.030 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 43 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 120 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2014 | 91 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 188 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 493 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 101 | 0.030 |
Why?
| | Spirometry | 1 | 2015 | 261 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2022 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 63 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 33 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 515 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2012 | 2145 | 0.030 |
Why?
| | Gene Expression | 1 | 2018 | 1487 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 350 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 144 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 180 | 0.030 |
Why?
| | Cell Separation | 1 | 2014 | 316 | 0.030 |
Why?
| | Nitrates | 1 | 2013 | 92 | 0.030 |
Why?
| | Connectome | 1 | 2014 | 87 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 409 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 546 | 0.020 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.020 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.020 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1751 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 42 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 346 | 0.020 |
Why?
| | Genetic Markers | 1 | 2013 | 347 | 0.020 |
Why?
| | Neural Pathways | 1 | 2014 | 297 | 0.020 |
Why?
| | DNA, Viral | 1 | 2014 | 369 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1859 | 0.020 |
Why?
| | Lubiprostone | 1 | 2012 | 9 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 312 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 9 | 0.020 |
Why?
| | Alprostadil | 1 | 2012 | 32 | 0.020 |
Why?
| | Infant, Premature | 1 | 2017 | 580 | 0.020 |
Why?
| | Phototrophic Processes | 1 | 2012 | 1 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 305 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 50 | 0.020 |
Why?
| | Hot Temperature | 1 | 2015 | 394 | 0.020 |
Why?
| | Electrolytes | 1 | 2012 | 57 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 99 | 0.020 |
Why?
| | Chlorine | 1 | 2012 | 61 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2838 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1322 | 0.020 |
Why?
| | Chloride Channel Agonists | 1 | 2012 | 84 | 0.020 |
Why?
| | Skin | 1 | 2016 | 753 | 0.020 |
Why?
| | Suction | 1 | 2011 | 33 | 0.020 |
Why?
| | Cyanobacteria | 1 | 2012 | 58 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 140 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 341 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 470 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 560 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 241 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 990 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5144 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2017 | 1100 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 510 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2198 | 0.020 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 46 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2013 | 396 | 0.020 |
Why?
| | Adiposity | 1 | 2015 | 527 | 0.020 |
Why?
| | Nutritional Status | 1 | 2013 | 354 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2012 | 199 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2012 | 758 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 445 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2730 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 310 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 589 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4160 | 0.020 |
Why?
| | Risk | 1 | 2011 | 906 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1089 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 3994 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1755 | 0.020 |
Why?
| | Thermus | 1 | 2007 | 1 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 826 | 0.020 |
Why?
| | Chloroflexi | 1 | 2007 | 12 | 0.020 |
Why?
| | Mining | 1 | 2007 | 22 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1544 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 980 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1431 | 0.020 |
Why?
| | Hospitalization | 1 | 2015 | 2195 | 0.010 |
Why?
| | Temperature | 1 | 2007 | 673 | 0.010 |
Why?
| | United States | 1 | 2015 | 15028 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2012 | 15750 | 0.010 |
Why?
|
|
Robertson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|